CIK: 0001782539 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 13, 2024
Total Value ($000): $116,070 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ILMN | ILLUMINA INC | 119,196 | $15,544 | 13.4% | $459.88 | -73.2% | COM | 452327109 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 368,665 | $14,747 | 12.7% | $30.00 | +17.1% | COM | 413197104 |
| GERN | GERON CORP | 1,373,550 | $6,236 | 5.4% | $2.56 | +77.6% | COM | 374163103 |
| — | MERUS N V | 120,038 | $5,997 | 5.2% | $27.41 | — | COM | N5749R100 |
| ZLAB | ZAI LAB LTD | 235,000 | $5,673 | 4.9% | $22.55 | — | ADR | 98887Q104 |
| — | LONGBOARD PHARMACEUTICALS IN | 160,570 | $5,352 | 4.6% | $23.66 | — | COM | 54300N103 |
| OCS | OCULIS HOLDING AG | 436,378 | $5,350 | 4.6% | $9.59 | +22.8% | ORDINARY SHARES | H5870P102 |
| ONC | BEIGENE LTD | 23,022 | $5,169 | 4.5% | $213.29 | — | SPONSORED ADR | 07725L102 |
| INCY | INCYTE CORP | 74,022 | $4,893 | 4.2% | $63.22 | +0.9% | COM | 45337C102 |
| XENE | XENON PHARMACEUTICALS INC | 106,680 | $4,200 | 3.6% | $18.43 | +118.7% | COM | 98420N105 |
| — | EXSCIENTIA PLC | 859,892 | $4,196 | 3.6% | $18.64 | — | ADS | 30223G102 |
| MIRM | MIRUM PHARMACEUTICALS INC | 106,100 | $4,138 | 3.6% | $29.88 | +33.5% | COM | 604749101 |
| — | TOURMALINE BIO INC | 146,800 | $3,774 | 3.3% | $14.30 | — | COM | 89157D105 |
| LAB | STANDARD BIOTOOLS INC | 1,883,179 | $3,635 | 3.1% | $2.41 | -18.9% | COM | 34385P108 |
| SLNO | SOLENO THERAPEUTICS INC | 63,950 | $3,229 | 2.8% | $47.87 | 0.0% | COM | 834203309 |
| REPL | REPLIMUNE GROUP INC | 287,846 | $3,155 | 2.7% | $15.16 | -33.0% | COM | 76029N106 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 49,120 | $2,573 | 2.2% | $27.85 | +72.0% | COM | 76243J105 |
| CLYM | ELIEM THERAPEUTICS INC | 463,654 | $2,360 | 2.0% | $7.07 | 0.0% | COM | 28658R106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 9,762 | $2,072 | 1.8% | $236.73 | +8.1% | COM | 558868105 |
| ASND | ASCENDIS PHARMA A/S | 13,600 | $2,031 | 1.7% | $151.17 | — | SPONSORED ADR | 04351P101 |
| KALV | KALVISTA PHARMACEUTICALS INC | 154,522 | $1,789 | 1.5% | $13.67 | -8.0% | COM | 483497103 |
| EXEL | EXELIXIS INC | 64,200 | $1,666 | 1.4% | $23.32 | +6.6% | COM | 30161Q104 |
| ACAD | ACADIA PHARMACEUTICALS INC | 102,984 | $1,584 | 1.4% | $23.42 | -28.8% | COM | 004225108 |
| RANI | RANI THERAPEUTICS HLDGS INC | 493,584 | $1,066 | 0.9% | $17.30 | -83.4% | COM CL A | 753018100 |
| TRDA | ENTRADA THERAPEUTICS INC | 49,082 | $784 | 0.7% | $9.39 | — | COM | 29384C108 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 10,815 | $760 | 0.7% | $88.26 | -5.3% | COM | 09061G101 |
| — | BOLT BIOTHERAPEUTICS INC | 1,166,952 | $756 | 0.7% | $15.46 | — | COM | 097702104 |
| BCYC | BICYCLE THERAPEUTICS PLC | 31,585 | $715 | 0.6% | $21.32 | — | SPONSORED ADS | 088786108 |
| — | BOLT PROJS HLDGS INC | 811,952 | $666 | 0.6% | $0.82 | — | COM | 09769B107 |
| KYMR | KYMERA THERAPEUTICS INC | 10,875 | $515 | 0.4% | $35.78 | +23.4% | COM | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 7,300 | $331 | 0.3% | $29.64 | +46.9% | COM | 76155X100 |
| — | SPRINGWORKS THERAPEUTICS INC | 7,450 | $239 | 0.2% | $49.22 | — | COM | 85205L107 |
| ARGX | ARGENX SE | 430 | $233 | 0.2% | $542.08 | — | SPONSORED ADR | 04016X101 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 3,820 | $212 | 0.2% | $50.94 | 0.0% | COM | 90400D108 |
| — | DBV TECHNOLOGIES S A | 185,475 | $130 | 0.1% | $0.80 | — | SPONSORED ADR | 23306J200 |
| AFMDQ | AFFIMED N V | 37,247 | $125 | 0.1% | $5.69 | -22.6% | ORDINARY SHS NEW | N01045207 |
| — | AEROVATE THERAPEUTICS INC | 47,936 | $100 | 0.1% | $29.30 | — | COM | 008064107 |
| ALXO | ALX ONCOLOGY HLDGS INC | 41,950 | $76 | 0.1% | $60.98 | -93.9% | COM | 00166B105 |